Chronic Opioid Therapy - Update
Estimated time to complete session: 60 mins.
Upon completion of this session, you should be able to:
1. Develop a protocol to identify those patients for whom opioid prescription is considered appropriate in accordance with the most recent CDC guidelines.
2. Point out the evidence surrounding risks associated with the concomitant use of opioids and benzodiazepines.
3. Identify non-opioid pharmacologic and nonpharmacologic methods to provide pain control for patients with chronic pain, or those at risk for developing chronic pain.
4. Describe the DEA registration process required to obtain prescribing privileges for buprenorphine/Medication Assisted Therapy (MAT).
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
David T. Walsworth, MD, FAAFP – Course Chair; Associate Chair for Clinical Affairs; Associate Professor, Department of Family Medicine, College of Human Medicine, Michigan State University, East Lansing
- 1.00 AAFP prescribed